George Soros’s Kymera Therapeutics KYMR Stock Holding History

George Soros’s Portfolio KYMR Stock Details KYMR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-120,373	Closed	-$4.84M	–	242
2024 Q4	$4.84M	Buy	+120,373	New	+$5.44M	0.07%	159

Other funds holding KYMR

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

AVLSA

Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

George Soros's KYMR Position: Q1 2025 in Review

George Soros sold out of Kymera Therapeutics (KYMR) in Q1 2025, closing a stake of 120,373 shares — an estimated $4.84M sold.

George Soros first reported a position in KYMR in Q4 2024 and held it in 1 quarter. The position peaked at $4.84M in Q4 2024. 173 funds tracked by Wall St. Rank hold KYMR as of Q1 2025.

George Soros reported no remaining Kymera Therapeutics position as of Q1 2025 after selling out during the quarter.
George Soros sold 120,373 Kymera Therapeutics shares in Q1 2025, an estimated $4.84M.
George Soros first reported a position in Kymera Therapeutics in Q4 2024 and held it in 1 quarter.
George Soros's Kymera Therapeutics position peaked at $4.84M in Q4 2024.
173 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q1 2025.

Based on Soros Fund Management's 13F filing for Q1 2025, filed 15 May 2025.